CLOV vs IDXX · rev $1.37B vs P/E 40, rev $3.90B
Clover Health Investments Corp (CLOV) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported IDXX revenue for 2024-12-31 was $3.90B. Net income was $887.9M. Revenue was up 6.5% from 2023-12-31 to 2024-12-31. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
CLOV currently screens at market cap $1.55B. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the CLOV and IDXX stock pages for the full models.
Not investment advice.